Commentary: "New York Times Piece on Drug Market Ignores the Data (and Reality)" Read more about Commentary: "New York Times Piece on Drug Market Ignores the Data (and Reality)"
Talking Points on JAMA Article: Trends in Prescription Drug Launch Prices, 2008-2021 Read more about Talking Points on JAMA Article: Trends in Prescription Drug Launch Prices, 2008-2021
NPC Comments on the Medicare Program's Hospital Inpatient Prospective Payment Systems Read more about NPC Comments on the Medicare Program's Hospital Inpatient Prospective Payment Systems
NPC Creates Guiding Principles for Designing and Evaluating Health Care Spending Research and Policies Read more about NPC Creates Guiding Principles for Designing and Evaluating Health Care Spending Research and Policies
Case Study: Using Health Care Spending Guiding Principles to Evaluate "Will Reducing Drug Prices Slow Innovation" Read more about Case Study: Using Health Care Spending Guiding Principles to Evaluate "Will Reducing Drug Prices Slow Innovation"
New Moves to Shine More Light Into an Opaque Drug Pricing System Read more about New Moves to Shine More Light Into an Opaque Drug Pricing System
Drug Price Regulation Trade-offs: Real or Imagined? Read more about Drug Price Regulation Trade-offs: Real or Imagined?
Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries Read more about Drug Price Controls in Medicare Part D: Not a Remedy for More Than 5 Million Medicare Beneficiaries
Patient-Centered Guiding Principles for Reforming Health Care to Address Rising Health Care Spending Read more about Patient-Centered Guiding Principles for Reforming Health Care to Address Rising Health Care Spending
Patient-Centered Guiding Principles for Evaluating Health Care Spending Read more about Patient-Centered Guiding Principles for Evaluating Health Care Spending